Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-11-14 | 2023-01-12 | 174595 |
TEVA-PRAZOSIN | 2MG | TABLET | Actual shortage | 2022-12-01 | 2023-12-21 | 176803 |
TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-12-01 | 2023-06-09 | 176818 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-12-08 | 2023-06-09 | 177526 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-01-12 | 2023-10-06 | 180891 |
TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183367 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-02-17 | 2023-04-28 | 185077 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2023-04-27 | 2023-07-14 | 190776 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-06-08 | 2023-10-03 | 194144 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-06-16 | 2023-07-05 | 195219 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195469 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-06-20 | 2023-07-05 | 195784 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-06-20 | 2023-10-19 | 195806 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2023-07-18 | 2023-07-21 | 198957 |
TEVA-TOLTERODINE | 2MG | TABLET | Actual shortage | 2023-10-05 | 2024-01-08 | 206413 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-10-19 | 2023-11-30 | 207533 |
TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Actual shortage | 2024-02-22 | 2024-03-14 | 220261 |
TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2020-03-06 | 2020-04-02 | 107978 |
TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139743 |
TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2022-09-07 | 2022-12-22 | 168744 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |